Join a panel of experts to discuss business strategies for commercializing and licensing AI innovations, how to build an IP portfolio that supports those strategies, and key terms to address in licensing negotiations from both the licensor and licensee perspective. Panelists will share insights on different approaches to commercializing and licensing AI technology, including AI platforms for drug discovery, generative AI platforms, and consumer products that incorporate AI functionality.

Moderator: Scott Forman, Of Counsel, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Speakers:

Jennifer Burdman, Managing Director, Sauvegarder Investment Management

Gideon Myles, Associate General Counsel, Patents and Trademarks, OpenAI

David Soucy, Senior Intellectual Property Counsel and Global Lead Patent Counsel, SimpliSafe